Liquid chromatography-mass spectrometry (LC-MS) is fast becoming the gold standard for biopharmaceutical analysis. However, identifying which LC-MS-based technique is best suited to a particular ...
Officials at BioAgilytix say the company has advanced its growth strategy with multi-million-dollar investments in liquid chromatography–mass spectrometry (LC/MS) capabilities, including new platforms ...
RNA-based therapeutics face challenges in bioanalysis, with experts recommending strategies to improve LC–MS performance and standardize ADME and DMPK practices. GLP-1 therapies require careful ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback